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Phosphoinositide-specific phospholipase C (PLC) is a crucial enzyme in transmembrane signaling. A cDNA encoding 
the putative phospholipase C was cloned from human lymphocytes that were transformed by infection with Epstein-Barr 
virus. The deduced amino acid sequence of the cDNA accounted for 146.1 kDa of the molecular mass of the complete 
enzyme and showed 50.2% sequence similarity to bovine brain PLC. This cDNA contained regions, the sequences of 
which were similar to those of some tyrosine kinase-related oncogene products. Northern blotting demonstrated that 
the mRNA for this PLC is expressed in human promyelocytic leukemia cells (HL-60). Since the other cloned cDNAs 
for PLCs could not hybridize with the RNA from this cell, it is strongly suggested that the gene obtained here encodes 
an additional isoxyme of PLC in blood cells. 
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1. INTRODUCTION 
Phosphoinositide-specific phospholipase C 
(PLC) is a crucial enzyme in transmembrane 
signaling that works by hydrolyzing phos- 
phatidylinositol 4,5bisphosphate to generate two 
messengers: the calcium mobilizer, inositol 
1,4,5_triphosphate and protein kinase C activator, 
1 ,Zdiacylglycerol [I ,2]. There have been many 
publications on the purification and characteriza- 
tion of PLCs from various tissues: rat liver 
(68 kDa) [3], sheep seminal vesicular gland 
(65 kDa) [4], bovine brain (88, 145 and 154 kDa) 
[5-71, rat brain (85 kDa) [8], guinea pig uterus 
(62 kDa) [9], calf thymocytes (68 kDa) [IO], 
bovine. platelets (143 kDa) [l l] and human 
platelets (61 kDa) [12]. The observed differences in 
molecular mass may indicate the presence of multi- 
ple forms of PLCs. 
To assess the multiplicity or diversity of PLC, 
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several laboratories have recently elucidated the 
primary structure of PLCs by cDNA cloning 
[ 13-181. We report the molecular cloning and se- 
quencing of a cDNA encoding the putative PLC in 
human lymphocytes transformed by Epstein-Barr 
virus. 
2. MATERIALS AND METHODS 
2.1. cDNA library from human lymphocytes 
The lymphocytes were transformed by infection with Epstein- 
Barr virus 1191 and cultured in RPM1 medium supplemented 
with 10% fetal bovine serum. Purification of poly(A+) RNA 
and construction of the hgtl0 library were performed as 
described [20,21]. From 1Opg of poly(A+) RNA, 10s recom- 
binants were obtained. 
2.2. Oligonucleotides 
Oligonucleotides for the cloning probes were synthesized in 
an automatic D_NA synthesizer model 380B (Applied 
Biosystem, CA, USA). The oligonucleotides GTITGIC- 
CITGITAIATIACIGGCATICCITCIGGICCITCCCAGCAIT- 
C and TCITAITCIGCICCIGCIACITCIATITCIACIAAIGG- 
ACAIACIATICC were selected by chance to encode some 
regions of the complementary sequences of bovine brain PLC 
[13] (the amino acid numbers from 367 to 383 and from 1106 
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to 1122, respectively). The 5 ‘-ends were labeled with 
[y-‘*P]ATP and Tq nucleotide kinase. 
2.3. Cloning and sequencing 
The cDNA library was screened with a mixture of the labeled 
oligonucleotides. Hybridization was performed at 45°C in 3 x 
SSC, 0.1% SDS, 10 x Denhart’s solution for 12 h, followed by 
washing with 2 x SSC and 0.1% SDS for 3 h at room 
temperature. The positive clones were purified by successive 


























G N T D R P DAS A V Y L H D F Q R FL I H E QQ E H WAQ D L N K V R E RM T 270 
CAAAGTTCATTGATGACACCATGCGTGAAACTGCTGAGCCTTTCTTGTTTGTGGATGAGTTCCTCACGTACCTGTTTTCACGAGAAAACAGCATCTGGGATGAGAAGTATGACGCGGTGG 1080 
K F I D D TM R E TA E P F L F V DE F L T Y L F S R E N S I W D E KY DA V D 310 
ACATGCAGGACATGAACAACCCCCTGTCTCATTACTGGATCTCCTCGTCACAT~CACGTACCTTACAGGTGACCAGCTGCGGAGCGAGTCGTCCCCAGAAGCTTACATCCGCTGCCTGC 1200 
MQ D M N N P L S H Y W I S S S H N T Y L TG D Q L R S E S S P E A Y I R C L R 350 
GCATGGGCTGTCGCTGCATTGAACTGGACTGCTGGGACGGGCCCGATGGGAAGCCGGTCATCTACCATGGCTGGACGCGGACTACCAAGATCAAGTTTGATGACGTCGTGCAGGCCATCA 1320 
MG C R C I E L D C W DG P D G K P V I Y H G W T R T T K I K F D D V V QA I K 390 
AAGACCACGCCTTTGTTACCTCGAGCTTCCCAGTGATCCTGTCCATCGAGGAGCACTGCAGCGTGGAGCAACAGCGTCACATGGCCAAGGCCTTC~GGAAGTATTTGGCGACCTGCTGT 1440 
D H A F V T S S F P V I L S I E E H C S V E 0 0 R H M A K A F K E V F G D L L L 430 
TGACGAAGCCCACGGAGGCCAGTGCTGACCAGCTGCCCTCGCCCAGCCAGCTGCGGGAGAAGATCATC~TC~AGCAT~GAAGCTGGGCCCCCGAGGCGATGTGGATGTCAACATGGAGG 1560 
T K P T E AS AD Q L P S P S Q L R E K I I I K H K K L G P R G D V D V NM E D 470 
ACAAGAAGGACGAACACAAGCAACAGGGGGAGCTGTACATGTGGGATTCCATTGACCAGAAATGGACTCGGCACTACTGCGCCATTGCTGATGCCAAGCTGTCCTTCAGTGATGACATTG 1680 
K K D E H K Q Q G E L Y M W D S 1 D Q K W T R H Y CA I AD AK L S F S D D I E 510 
AACAGACTATGGAGGAGGAAGTGCCCCAGGATATACCCCCTACAGAACTACATTTTGGGGAGAAATGGTTCCACAAGAAGGTGGAGAAGAGGACGAGTGCCGAG~GTTGCTGCAGGAAT 1800 
Q TM E E E V PQ D I P P T E L H F G E K W F H K K V E K R T S A E K L LQ E Y 550 
ACTGCATGGAGACGGGGGGCAAGGATGGCACCTTCCTGGTTCGGGAGAGCGAGACCTTCCCCAATGACTACACCCTGTCCTTCTGGCGGTCAGGCCGGGTCCAGCACTGCCGGATCCGCT 1920 
CM E T G G K D G T F L V R E S E T F P N D Y T L S F W R S G R V Q H C R I R S 590 
CCACCATGGAGGGCGGGACCCTGAAATACTACTTGACTGACAACCTGAGGTTCAGGAGGATGTATGCCCTCATCCAGCACTACCGCGAGACGCACCTGCCGTGCGCCGAGTTCGAGCTGC 2040 
TM E GG T L K Y Y L T D N L R F R RM Y A L I Q H Y RET H L P C A E F E L R 630 
GGCTCACGGACCCTGTGCCCAACCCCAACCCCCACGAGTCCAAGCCGTGGTACTATGACAGCCTGAGCCGCGGAGAGGCAGAGGACATGCTGATGAGGATTCCCCGGGACGGGGCCTTCC 2160 
L T D P V P N P N P H E S K P W Y Y D S L S R G E A E D M L M R I P R D G A F L 670 
TGATCCGGAAGCGAGAGGGGAGCGACTCCTATGCCATCACCTTCAGGGCTAGGGGCAAGGTAAAGCATTGTCGCATCAACCGGGACGGCCGGCACTTTGTGCTGGGGACCTCCGCCTATT 2280 
I R K R E G S D S Y A I T F R A R G K V K H CR I N R D G R H F V L G T S A Y F 710 
TTGAGAGTCTGGTGGAGCTCGTCAGTTACTACGAGAAGCATTCACTCTACCG~AGATGAGACTGCGCTACCCCGTGACCCCCGAGCTCCTGGAGCGCTACAATACGG~GAGATATAA 2400
E S L V E L V S Y Y E K H SLY R K M R L R Y P V T P E L L E R Y N T E R D I N 750 
ACTCCCTCTACGACGTCAGCAGAATGTATGTGGATCCCAGTGA~TCAATCCGTCCATGCCTCAGAG~CCGTGAAAGCTCTGTATGACTAOAAAGCCAAGCGAAGCGATGAGCTGAGCT 2520 
S L Y D V S RM Y V D P S E I N P SM PQ R T V K A L Y D Y KA K R S D E L S F 790 
TCTGCCGTGGTGCCCTCATCCACAATGTCTCCAAGGAGCCCGGGGGCTGGTGG~AGGAGACTATGG~CCAGGATCCAGCAGTACTTCCCATCCAACTACGTCGAGGACATCTCAACTG 2640 
C RG A L I H N V SK E P G G W W KG D Y GT R I QQ Y F P S N Y V E D I S TA830 
CAGACTTCGAGGAGCTAGAAAAGCAGATTATTGAAGACAATCCCTTAGGGTCTCTTTGCAGAGGAATATTGGACCTCAATACCTATAACGTCGTGA~GCCCCTCAGGGAAAAAACCAGA 2760 
D F E E L E K Q I IE D N P L G S L C RG I L D L N T Y N V V KA PQ G K N Q K 870 
AGTCCTTTGTCTTCATCCTGGAGCCCAAGGAGCAGGGCGATCCTCCGGTGGAGTTTGCCACAGACAGGGTGGAGGAGCTCTTTGAGTGGTTTCAGAGCATCCGAGAGATCACGTGGAAGA 2880 
S F V F I L E P K E Q G D P P V E F AT D R V E E L F E W F Q S I R E 1 T W K 1910 
TTGACAGCAAGGAGAACAACATGAAGTACTGGGAGAAGAACCAGTCCATCGCCATCGAGCTCTCTGACCTGGTTGTCTACTGCAAACCAACCAGCAA~CCAAGGACAACTTAGA~ATC 3000 
D S K EN NM K Y W E K N Q S I A I E LSD L V V Y C K P T S K T K D N LEN P 950 
CTGACTTCCGAGAAATCCGCTCCTTTGTGGAGACGAAGGCTGACAGCATCATCAGACAGAAGCCCGTCGACCTCCTGAAGTACAATCAAAAGGGCCTGACCCGCGTCTACCCAAAGGGAC 3120 


















Fig. 1. Nucleotide sequence of the putative phospholipase C and the deduced amino acid sequence. The first methionine in the open 
reading frame is proposed to the initiation codon and the numbers start at the methionine for the deduced sequence. 
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Human PLC 312 
Rat PLC I 316 
Rat PLC II 320 
Rat PLC III 296 
Human PLC 
Rat I PLC 
Rat II PLC 
Rat III PLC 
Human PLC 
Rat I PLC 
Rat II PLC 
Rat III PLC 
Human PLC 
Rat I PLC 
Rat II PLC 
Rat III PLC 
Human PLC 929 
Rat I PLC 539 
Rat II PLC 952 
Rat III PLC 491 
Human PLC 
Rat I PLC 
Rat II PLC 
Rat III PLC 
Human PLC 
Rat I PLC 
Rat II PLC 
Rat III PLC 





Human PLC 777 
v-crk 375 
v-src 88 
Human PLC 532 
Human PLC 646 
v-crk 248 
v-src 140 
Human FLC 710 ES 
v-crk 330 DS 
v-src 212 i&Z 
Fig.2 Comparison of part of the amino acid sequence with the sequences of other PLCs and tyrosine kinase-related oncogene 
products. The identical or conservatively changed amino acids are enclosed in boxes. See [13,14,16] for the published sequences. 
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the purified phage DNA (EcoRI and Hind111 fragments) were 
directly analyzed by sequencing as described [22] (one of the 
Hind111 sites is located in the hgtl0 DNA and one of the EcoRI 
sites is located in the cloning site). 
3.3. Northern blotting 
Northern blotting was performed as described [23]. The 
EcoRI fragment of the cDNA was used as the hybridization 
probe. 
3. RESULTS AND DISCUSSION 
A human cDNA library of transformed lym- 
phocytes was screened with oligonucleotide probes 
as described in section 2. Out of 1.2 x lo6 recom- 
binants, three positive clones were isolated and 
purified. Since the nucleotide sequence of the in- 
sert suggested that it did not contain the full length 
of the cDNA, the library was screened again with 
the cloned insert as the probe. The nucleotide se- 
quence and the deduced amino acid sequence of 
the longest insert are shown in fig. I. The parts of 
the deduced amino acid sequence were compared 
with those of the published PLCs [14,16] as il- 
lustrated in fig.2. The similarity of the deduced 
amino acid sequence to the published sequences 
strongly suggest hat the cDNA encodes a kind of 
PLC. Although 97% of the amino acids of the 
bovine brain 14%PLC 1131 were identical with 
those of the rat brain (PLC II) [13], only 50.2% of 
the total amino acids were identical with PLC II 
(rat brain) or 148-PLC (bovine brain) by a max- 
imum matching method. In addition, this cDNA 
contained regions, the sequences of which were 
similar to those of some tyrosine kinases-related 
oncogene products (fig.2). 
In Northern blot experiments, three bands of 
poly(A+) RNA prepared from human pro- 
myelocytic leukemia cells (HL-60) were hybridized 
with the cloned cDNA under weakly stringent con- 
ditions (indicated by arrows in fig.3). Only one 
band was hybridized under strongly stringent con- 
ditions (fig.3). Since the published clones [13,15] 
could be hybridized with human fibroblast RNA 
but not with HL-60 RNA, this putative PLC 
cDNA should be a different species of isozyme. In 
addition, the Northern blot experiment suggests 
that HL-60 cells may contain two additional 
isozymes of PLC. One of them may be a PLC of 
61 kDa that was purified from human platelet 
membrane [121. The interaction between PLC and 




Fig.3. Northern blotting of mRNA from HL-60. Hybridization 
was performed using the ‘Rapid hybridization system’ 
(Amersham) at 55’C, and the membrane was washed with 2 x 
SSC and 0.1% SDS for 2 h at room temperature, then for 1 h 
at 55°C (lane 1) and for an additional 1.5 h at 65°C with 0.1% 
SDS and 0.1 x SSC (lane 2). 
HL-60 [24]. Therefore, this clone will be potentiaf- 
ly useful for various investigations on transmem- 
brane signaling at the cellular level. 
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